key: cord-0050069-3ki4fcdc
authors: Torres, Angeli Eloise; Lyons, Alexis B.; Hamzavi, Iltefat H.; Lim, Henry W.
title: Response to Commentary on “Role of Phototherapy in the Era of Biologics”
date: 2020-09-17
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.09.040
sha: 788b7049e8de90036db8207e08fef3fa5d188e72
doc_id: 50069
cord_uid: 3ki4fcdc

nan

expounds on the potential harm associated with the combination of narrowband ultraviolet (UV) 34 B (NB-UVB) phototherapy and immunosuppressive agents, specifically, tumor necrosis factor 35 inhibitors (anti-TNF). 36

Having been around for over four decades, phototherapy has a well-known efficacy and 37 long-term safety profile. Since immunosuppression is one of the key mechanisms by which 38 phototherapy controls inflammatory skin diseases, 2 the risk of immunosuppression and 39 subsequent cancer development is of particular concern especially when phototherapy is Finally, care must be taken when extrapolating data obtained from in vitro or animal 65 studies into clinical practice. The mouse study conducted by Dr. Botsali and colleagues provided 66 valuable insight into the potential additive carcinogenic effect of combining NB-UVB with anti-67 TNF agents. 5 However, as the commenting author recognized, these results cannot be readily 68 applied to the human population. This is because while useful information can be obtained from 69 in vitro or animal models, they often lack the intricacies and complex interplay of human 70 anatomy and physiology. 71

In summary, the aim of the review, "Role of Phototherapy in the Era of Biologics" was to 72 emphasize the utility, cost-effectiveness, and versatility of phototherapy as a treatment option.

Commentary on "role of phototherapy in the era of biologics

Role of phototherapy in the era of biologics

Incidence of skin cancers in 3867 81 patients treated with narrow-band ultraviolet B phototherapy

Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a 84 COVID-19 Outbreak

Anti-TNF 86 agent etanercept augments UV-induced skin cancer development in SKH-1 mice(dagger)